---
title: Cellab CDMO vs Hillgene
slug_a: cellab
slug_b: hillgene
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cellab/hillgene
generated_by: BioBM Editorial AI
---

# Cellab CDMO vs Hillgene

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Cellab CDMO (cellab) is listed for cdmo. Cell and gene therapy CDMO providing cell banking, GMP manufacturing, cryopreservation and EU QP batch release for clinical-stage ATMPs. Operates a 1,000 m² facility with four Grade B and one Grade C cleanroom plus an AABB-accredited cell bank.

Services: 7. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Hillgene (hillgene) is listed for cdmo. Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.

Services: 8. Modalities: 3. Indications: 2. Locations: 3. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.